Transmission of Cytomegalovirus ( CMV ) from CMV‐Seropositive Organ Donors to CMV‐Seronegative Pediatric Solid Organ Transplant ( SOT ) Recipients

Key Points

• The aim is to identify factors that prevent CMV transmission to seronegative recipients despite receiving organs from seropositive donors.
• Analyzed transplant cases involving CMV-seropositive donors and seronegative recipients.
• Examined factors influencing viral transmission and recipient outcomes.
• Evaluated the effectiveness of antiviral prophylaxis in preventing CMV infection.
• Identified specific conditions under which CMV transmission does not occur.
• Found a potential link between antiviral prophylaxis and reduced transmission rates in seronegative recipients.